<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To review the evidence on interventions for reversing <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> or preventing development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> in people with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A systematic review and Bayesian mixed treatment comparison meta-analysis was conducted </plain></SENT>
<SENT sid="2" pm="."><plain>Relevant electronic bibliographic databases were searched up to January 2010 </plain></SENT>
<SENT sid="3" pm="."><plain>Included studies were randomized controlled trials with a follow-up of â‰¥24 weeks and outcomes comparing incidence of <z:mp ids='MP_0002055'>diabetes</z:mp> and/or <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, or reversal of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A total of 16 studies met the inclusion criteria </plain></SENT>
<SENT sid="5" pm="."><plain>Thirteen studies with outcome data for reversal of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, involving 3907 participants, were included in the meta-analysis </plain></SENT>
<SENT sid="6" pm="."><plain>Insufficient trials reported cardiovascular events/mortality, or incidence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, to conduct a meta-analysis for these outcomes </plain></SENT>
<SENT sid="7" pm="."><plain>Interventions, alone or in combination, included lifestyle (diet and/or exercise) and pharmacological therapy </plain></SENT>
<SENT sid="8" pm="."><plain>Using random-effect models, both lifestyle (odds ratio, OR 3.81; 95% confidence interval, CI 2.47-5.88) and pharmacological interventions (OR 1.59; 95% CI 1.04-2.45) were statistically superior compared with control for reversing <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Using mixed treatment comparison methods, the probability that lifestyle interventions were the most clinically effective was 87% </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Evidence suggests that both lifestyle and pharmacological interventions can reverse <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>However, there is a lack of data on whether these benefits are sustained and translate into longer term prevention of <z:mp ids='MP_0002055'>diabetes</z:mp> and/or <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
</text></document>